img

Global Swedish Porphyria Therapeutics Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Swedish Porphyria Therapeutics Market Research Report 2024

Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.
According to MRAResearch’s new survey, global Swedish Porphyria Therapeutics market is projected to reach US$ 56 million in 2033, increasing from US$ 49 million in 2022, with the CAGR of 1.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Swedish Porphyria Therapeutics market research.
Panhematin (hemin) is a medication used to treat acute porphyria, a rare genetic disorder that affects heme production. Its effectiveness in managing acute porphyria attacks and reducing symptoms has driven market growth. The rarity of the condition and limited treatment options contribute to its niche status. However, challenges include the need for careful monitoring and potential side effects. The market competition is relatively small, as Panhematin remains a specialized therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Swedish Porphyria Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Recordati Rare Diseases
Segment by Type
350mg
313mg

Segment by Application


Hospital
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Swedish Porphyria Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Swedish Porphyria Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 350mg
1.2.3 313mg
1.3 Market by Application
1.3.1 Global Swedish Porphyria Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Swedish Porphyria Therapeutics Market Perspective (2018-2033)
2.2 Swedish Porphyria Therapeutics Growth Trends by Region
2.2.1 Global Swedish Porphyria Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Swedish Porphyria Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Swedish Porphyria Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Swedish Porphyria Therapeutics Market Dynamics
2.3.1 Swedish Porphyria Therapeutics Industry Trends
2.3.2 Swedish Porphyria Therapeutics Market Drivers
2.3.3 Swedish Porphyria Therapeutics Market Challenges
2.3.4 Swedish Porphyria Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Swedish Porphyria Therapeutics Players by Revenue
3.1.1 Global Top Swedish Porphyria Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Swedish Porphyria Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Swedish Porphyria Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Swedish Porphyria Therapeutics Revenue
3.4 Global Swedish Porphyria Therapeutics Market Concentration Ratio
3.4.1 Global Swedish Porphyria Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Swedish Porphyria Therapeutics Revenue in 2022
3.5 Swedish Porphyria Therapeutics Key Players Head office and Area Served
3.6 Key Players Swedish Porphyria Therapeutics Product Solution and Service
3.7 Date of Enter into Swedish Porphyria Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Swedish Porphyria Therapeutics Breakdown Data by Type
4.1 Global Swedish Porphyria Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Swedish Porphyria Therapeutics Forecasted Market Size by Type (2024-2033)
5 Swedish Porphyria Therapeutics Breakdown Data by Application
5.1 Global Swedish Porphyria Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Swedish Porphyria Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Swedish Porphyria Therapeutics Market Size (2018-2033)
6.2 North America Swedish Porphyria Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Swedish Porphyria Therapeutics Market Size by Country (2018-2023)
6.4 North America Swedish Porphyria Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Swedish Porphyria Therapeutics Market Size (2018-2033)
7.2 Europe Swedish Porphyria Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Swedish Porphyria Therapeutics Market Size by Country (2018-2023)
7.4 Europe Swedish Porphyria Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Swedish Porphyria Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Swedish Porphyria Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Swedish Porphyria Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Swedish Porphyria Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Swedish Porphyria Therapeutics Market Size (2018-2033)
9.2 Latin America Swedish Porphyria Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Swedish Porphyria Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Swedish Porphyria Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Swedish Porphyria Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Swedish Porphyria Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Swedish Porphyria Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Swedish Porphyria Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recordati Rare Diseases
11.1.1 Recordati Rare Diseases Company Detail
11.1.2 Recordati Rare Diseases Business Overview
11.1.3 Recordati Rare Diseases Swedish Porphyria Therapeutics Introduction
11.1.4 Recordati Rare Diseases Revenue in Swedish Porphyria Therapeutics Business (2018-2023)
11.1.5 Recordati Rare Diseases Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Swedish Porphyria Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of 350mg
Table 3. Key Players of 313mg
Table 4. Global Swedish Porphyria Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Swedish Porphyria Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Swedish Porphyria Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Swedish Porphyria Therapeutics Market Share by Region (2018-2023)
Table 8. Global Swedish Porphyria Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Swedish Porphyria Therapeutics Market Share by Region (2024-2033)
Table 10. Swedish Porphyria Therapeutics Market Trends
Table 11. Swedish Porphyria Therapeutics Market Drivers
Table 12. Swedish Porphyria Therapeutics Market Challenges
Table 13. Swedish Porphyria Therapeutics Market Restraints
Table 14. Global Swedish Porphyria Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Swedish Porphyria Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top Swedish Porphyria Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swedish Porphyria Therapeutics as of 2022)
Table 17. Ranking of Global Top Swedish Porphyria Therapeutics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Swedish Porphyria Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Swedish Porphyria Therapeutics Product Solution and Service
Table 21. Date of Enter into Swedish Porphyria Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Swedish Porphyria Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Swedish Porphyria Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Swedish Porphyria Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Swedish Porphyria Therapeutics Revenue Market Share by Type (2024-2033)
Table 27. Global Swedish Porphyria Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Swedish Porphyria Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global Swedish Porphyria Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Swedish Porphyria Therapeutics Revenue Market Share by Application (2024-2033)
Table 31. North America Swedish Porphyria Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Swedish Porphyria Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Swedish Porphyria Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Swedish Porphyria Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Swedish Porphyria Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Swedish Porphyria Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Swedish Porphyria Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Swedish Porphyria Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Swedish Porphyria Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Swedish Porphyria Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Swedish Porphyria Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Swedish Porphyria Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Swedish Porphyria Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Swedish Porphyria Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Swedish Porphyria Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Recordati Rare Diseases Company Detail
Table 47. Recordati Rare Diseases Business Overview
Table 48. Recordati Rare Diseases Swedish Porphyria Therapeutics Product
Table 49. Recordati Rare Diseases Revenue in Swedish Porphyria Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Recordati Rare Diseases Recent Development
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Swedish Porphyria Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Swedish Porphyria Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. 350mg Features
Figure 4. 313mg Features
Figure 5. Global Swedish Porphyria Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Swedish Porphyria Therapeutics Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Swedish Porphyria Therapeutics Report Years Considered
Figure 10. Global Swedish Porphyria Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Swedish Porphyria Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Swedish Porphyria Therapeutics Market Share by Region: 2022 VS 2033
Figure 13. Global Swedish Porphyria Therapeutics Market Share by Players in 2022
Figure 14. Global Top Swedish Porphyria Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swedish Porphyria Therapeutics as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Swedish Porphyria Therapeutics Revenue in 2022
Figure 16. North America Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Swedish Porphyria Therapeutics Market Share by Country (2018-2033)
Figure 18. United States Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Swedish Porphyria Therapeutics Market Share by Country (2018-2033)
Figure 22. Germany Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Swedish Porphyria Therapeutics Market Share by Region (2018-2033)
Figure 30. China Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Swedish Porphyria Therapeutics Market Share by Country (2018-2033)
Figure 38. Mexico Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Swedish Porphyria Therapeutics Market Share by Country (2018-2033)
Figure 42. Turkey Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Swedish Porphyria Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Recordati Rare Diseases Revenue Growth Rate in Swedish Porphyria Therapeutics Business (2018-2023)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries